Pharmaceutical Grade API 99% CAS 183133-96-2 Cabazitaxel

Short Description:

Cabazitaxel API can inhibit the growth of cancer cells and even cause cancer cells to die. Currently on the market, cabazitaxel developed by Sanofi-aventis is a second-line drug for prostate cancer, specifically a chemical semi-synthetic taxane-like small molecule compound. Hande Bio provides Pharmaceutical Grade API 99%CAS 183133-96-2 Cabazitaxel. For more details, please contact us online.


Product Detail

Product Tags

Product Informations

Name: Cabazitaxel

CAS number: 183133-96-2

Chemical formula: C45H57NO14

Specifications: 99%

Color: white or off-white powder

Source: Semi-synthesized with 10-DAB

Type: APIs

Shelf life

Storage conditions: sealed, protected from light, dry, controlled at room temperature.

Hande production capacity

Production cycle: 30-45 days.

Production batch: one batch can produce about 15kg.

Hande production capacity: there is inventory and can be mass produced.

Hande production advantages

Hande, which has built its own GMP production base, has passed the review of laws and regulations of FDA, EDQM, GMP in China, PMDA in Japan, TGA in Australia, South Korea, India, Taiwan, China, Türkiye, Russia, SGS, Dun&Bradley, etc. At the same time, the company is equipped with a research and development team and has successively obtained a number of patents. QC testing room, highly realizing product project testing.

Our Services

1.Products:Provide high-quality,high-purity plant extracts,pharmaceutical raw materials,and pharmaceutical intermediates.

2.Technical services:Customized extracts with special specifications according to customer requirements.

Hande factory

Be the best supplier of raw materials and enterprises with integrity!

Welcome to contact me by sending email to marketing@handebio.com


  • Previous:
  • Next: